This event has passed.

2nd Hellenic Biocluster Forum

Name: 2nd Hellenic Biocluster Forum
Start: 2021-11-04T08:00:00+01:00
End: 2021-11-05T17:30:00+01:00

4 November 2021 @ 8:00 am – 5 November 2021 @ 5:30 pm CET

HBio is a strong innovation moderator, connecting and supporting industry and academia partners to develop innovative and impact science. The Hellenic Biocluster delivers connectivity to the global science and technology frontiers for more than 65 partners, with the vision to continue being a catalyst, adding value to the innovation performance of its’ partners and Greece as a whole.

HBio is pleased to host the 2nd Hellenic Biocluster Forum in Athens, on November 4-5, 2021. EuropaBio’s Director-General, Dr. Claire Skentelbery, will speak at the panel “Vision for Life Sciences and Biotechnology for a Healthy and Sustainable EU”, on November 4, from 09.00 to 09.45 CET.

Event Navigation

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.